1. Ma, Wenping, Bao, Zhaoshi, Qian, Zenghui, Zhang, Ying, Jiang, Tao. 2022. LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma. In CNS neuroscience & therapeutics, 28, 873-883. doi:10.1111/cns.13817. https://pubmed.ncbi.nlm.nih.gov/35338570/
2. Wen, Yifan, Wang, Eryao, Wang, Xianwei, Zhang, Zijing, Huang, Yongzhen. 2022. Copy number variations of LRRFIP1 gene and the relationship with growth traits in four Chinese sheep. In Animal biotechnology, 34, 3008-3015. doi:10.1080/10495398.2022.2126981. https://pubmed.ncbi.nlm.nih.gov/36170043/
3. Takimoto, Masato. 2019. Multidisciplinary Roles of LRRFIP1/GCF2 in Human Biological Systems and Diseases. In Cells, 8, . doi:10.3390/cells8020108. https://pubmed.ncbi.nlm.nih.gov/30709060/
4. Li, Jinping, Tuo, Dayun, Guo, Gunan, Gao, Yan, Gan, Jinfeng. 2024. The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer. In Discover oncology, 15, 123. doi:10.1007/s12672-024-00977-3. https://pubmed.ncbi.nlm.nih.gov/38634978/
5. Qian, You-Wen, Wang, Eunice S, Sait, Sheila Jani, Glenn, Sean T. 2023. Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype. In Cancer genetics, 278-279, 50-54. doi:10.1016/j.cancergen.2023.08.004. https://pubmed.ncbi.nlm.nih.gov/37597337/
6. Liu, Weifeng, Duan, Qianqian, Gong, Lihua, Guo, Hao, Niu, Xiaohui. 2020. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib. In Investigational new drugs, 39, 278-282. doi:10.1007/s10637-020-00984-5. https://pubmed.ncbi.nlm.nih.gov/32915420/
7. Douchi, Daisuke, Ohtsuka, Hideo, Ariake, Kyohei, Egawa, Shinichi, Unno, Michiaki. 2015. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. In Cancer letters, 365, 132-40. doi:10.1016/j.canlet.2015.05.023. https://pubmed.ncbi.nlm.nih.gov/26047573/
智鼠故事 
